In The Pipeline
-
1.3KiVeena’s IVMED-85 Receives NEI-SBIR Grant
October 27, 2023 SALT LAKE CITY — iVeena Delivery Systems‘ Dr. Sarah Molokhia, vice president of research and development, was awarded a...
-
1.5KProf. Dr. Jens Ellrich Named Chief Scientific Officer at Dopavision
March 21, 2023 BERLIN, Germany — Professor Dr. Jens Ellrich has been named the new Chief Scientific Officer at Dopavision, a clinical-stage...
-
816Artificial Intelligence and Fundus Photography Can Predict High Myopia
October 17, 2022 By Li Lian Foo, MD, MMed (Ophth), FRCOphth, BEng (1st class honors) With the recent development of several enterprise-grade...
-
2.5KOcuco Invests in Ocumetra to Support ECPs Delivering Myopia Management
December 16, 2021 DUBLIN, Ireland — Ocuco has invested in Ocumetra, a data science solutions company dedicated to myopia management. As a part...
-
2.0K‘Up Close With’ Ian Flitcroft, James Loughman, and Leo Mac Canna About Ocumetra/Ocuco Software for Myopia Management
December 17, 2021 Ocumetra was founded in 2020 by Professor Ian Flitcroft and Professor James Loughman, leaders in the field of myopia...
-
1.6KA Smartphone-Based Treatment for Childhood Myopia
November 15, 2021 By Hamed Bahmani, BEng, MSc, PhD A smartphone application, MyopiaX is a non-invasive digital treatment designed to achieve a...
-
3.0KKubota Vision Receives ISO Certification
October 19, 2021 SEATTLE — Kubota Vision, a subsidiary of Kubota Pharmaceutical Holdings Co., announced that it has received ISO 13485:2016 certification for...
-
2.9KAdvancing Myopia Therapy with IVMED-85
October 15, 2021 By Bala Ambati, MD, PhD, President and Founder, iVeena & Sarah Molokhia, RPh, PhD, VP for Research & Development,...
-
3.3KVyluma: Leading with Innovation
sponsored content October 1, 2021 By Dwight Akerman, OD, MBA, FAAO, FBCLA Vyluma is dedicated to using its deep expertise to develop...
-
2.8KDeveloping New Anti-Myopia Drugs
September 15, 2021 By Andrei V. Tkatchenko, MD, PhD, and Tatiana V. Tkatchenko, MD The development of effective and safe drugs for...
-
3.1KNovaSight Uses Eye-Tracking Technology to Develop Myopia Management Lens
June 15, 2021 By Ran Yam, Prof. Michael Belkin, MA, MD, Liran Adlin, Nancy LeBosquain The therapeutic principle is similar to the...
-
2.8KOIS Hosts Virtual Myopia Innovation Showcase
April 30, 2021 The Ophthalmology Innovation Summit (OIS) hosted a virtual Myopia Innovation Showcase on Thursday, April 29. The session started with...
-
6.8KNew Technology Records Visual Behavior to Identify Risk Factors of Myopia Progression
April 15, 2021 By Andreas Kelch & Daniel Boss Vivior can offer added value for myopia management by recording the objective visual...
-
6.8KCan Augmented Reality Slow Myopia?
March 15, 2021 By Larry Baitch, OD, PhD, FAAO Arkady Selenow, OD, FAAO, ABO Nabin Joshi, PhD Inna Samandarova, PharmD “This part-time...
-
7.0KEssilor’s Rick Gadd Discusses Acquisition of SightGlass
March 3, 2021 Rick Gadd, President, Essilor North America, recently met with Review of Myopia Management’s Editor-in-Chief John Sailer to discuss the company’s...
-
4.4KCooperVision President Daniel McBride Discusses Acquisition of SightGlass
March 3, 2021 Last month, CooperCompanies and EssilorLuxottica announced that they were teaming up to acquire SightGlass Vision. The goal of the joint...
-
4.5KCooperVision and EssilorLuxottica Partner to Commercialize SightGlass Myopia Management Lens
February 3, 2021 SAN RAMON, Calif. and CHARENTON-LE-PONT, France – CooperCompanies and EssilorLuxottica entered a joint venture agreement to accelerate commercialization of...
-
5.4KInvestigational and Early-stage Myopia Interventions – A Farsighted View
November 1, 2020 By Thomas Aller, OD, FBCLA Collaborator, BHVI With the increasing incidence of myopia all around the world, predictions of...
-
3.4KSightglass Vision Reports 12-month Results for its CYPRESS Study
October 9, 2020 An ongoing CYPRESS study of Sightglass Vision’s novel eyeglasses designed to slow progression of myopia in children “demonstrated the...
-
3.3KKubota Vision Announces University Research Agreement for its Wearable Myopia-control Device
July 22, 2020 Kubota Vision Inc., a clinical-stage ophthalmology company and wholly owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd., today announced...
-
4.0KSightGlass Vision Achieves CE Mark Allowing European Marketing for Novel Eyeglasses
June 3, 2020 PALO ALTO, California – SightGlass Vision, Inc. today announced it has achieved Conformité Européene (CE) Mark declaration on its first product...
-
4.3KKubota Vision Introduces Electronic Eyeglasses to Stop Myopia in Children
May 19, 2020 Kubota Vision today announced positive clinical results from myopia control tests in humans. Utilizing electronic tabletop optical projection devices...
-
24.0KNovel DOT Lenses from SightGlass Vision Show Great Promise to Fight Myopia
April 21, 2020 By Joe Rappon, OD, MS, FAAO Jay Neitz, PhD Maureen Neitz, PhD Spectacles have been the mainstay modality for...
-
2.5KSightGlass Vision Reports Positive Interim Data From Pivotal Clinical Trial of Novel Eyeglasses for Myopia Management in Children
April 2, 2020 Palo Alto, California – SightGlass Vision, Inc., a clinical-stage life sciences company focused on ending myopia, announced topline results from a...
-
3.5KSightGlass Presents CYPRESS Study Baseline Data at International Myopia Conference
CYPRESS is a multi-center, double-masked, randomized controlled pivotal clinical study.